OBJECTIVES: To compare nocturnal deactivation with nocturnal activation of the artificial urinary sphincter (AUS) to determine whether nocturnal deactivation reduces the risk of @entity194 and subsequent recurrent @entity322 . To the best of our knowledge, no review comparing these two approaches has been performed. METHODS: At the Mayo Clinic, all @entity1 are instructed to deactivate their AUS at night; at Baylor, all @entity1 keep their AUS activated all the time. At each institution, a group of consecutive @entity1 with comparable severe @entity322 after radical retropubic prostatectomy were selected; 61 and 46 @entity1 from the Mayo Clinic and Baylor, respectively, were available for review. All Mayo Clinic @entity1 strictly adhered to nocturnal deactivation of their AUS and all 46 @entity1 from Baylor kept their AUS activated at all times, except during voiding. Each @entity1 was reviewed for the long-term risk of subsequent reoperation, especially regarding recurrent @entity322 due to @entity194 . RESULTS: Seventeen (27.8%) of the 61 @entity1 from Mayo (mean follow-up 40 months) required a repeated operation. Of the 17 AUS failures, 6 (35%) were due to @entity194 . Of the 46 @entity1 from Baylor (mean follow-up 28 months), 16 (34.7%) required a repeated operation. Of the 16 AUS failures, 10 (62%) were due to @entity194 . Overall, the @entity1 who nocturnally deactivated their AUS had a 10% risk of @entity194 -related @entity322 compared with a 21% risk in the nocturnally activated group. CONCLUSIONS: Although not statistically significant, nocturnal deactivation appears to decrease the risk of @entity194 and recurrent @entity322 (10% versus 21%). Nocturnal deactivation should be considered in @entity1 who are dry at night and have sufficient motivation to lessen the risk of @entity194 secondary to cuff compression.

Does nocturnal deactivation of the artificial urinary sphincter lessen the risk of XXXX ?

@entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'men'] @entity194 :: ('MESH:D001284', 'Disease') :: ['urethral atrophy', 'atrophy'] @entity322 :: ('MESH:D014549', 'Disease') :: ['urinary incontinence', 'incontinence']
@entity194 :: (MESH:D001284,Disease) :: ['urethral atrophy']
